Physician profile

Christopher R Ellis

Cardiovascular Disease · Nashville, TN

NPI 1528174752

$527,201.58

in general payments reported to CMS, 2019-2025

17 companies · $79K in 2025

The $79K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$116,612.50
Travel and Lodging$49,858.04
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$38,475.00
Food and Beverage$20,213.11

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $295,173.23 2019-2025 Amplatzer Amulet, Jeti All In One Non-Sterile Kit, Ensite Precision
Boston Scientific Corporation $156,044.90 2019-2025 Watchman Flx, Versacross Access Solution, Watchman Access System
Medtronic, INC. $32,201.05 2021-2025 Micra, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan
Atricure, INC. $19,014.00 2019-2025 Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Lariat Rs
Medtronic Vascular, INC. $9,123.75 2019-2020
Biosense Webster, INC. $7,155.01 2020-2025 Carto 3, Thermocool Sf
Philips North America LLC $4,294.14 2019-2025 Igt Devices Undivided, (9124) Lm Undivided, (9520) Igt Devices Undivided
Biotronik INC. $3,888.87 2019-2020
Microtransponder, INC. $123.32 2023
Tactile Systems Technology INC $49.93 2022
Siemens Medical Solutions USA, INC. $37.21 2020
Acutus Medical, INC. $36.98 2021
Bayer Healthcare Pharmaceuticals INC. $26.24 2023
Cvrx, INC. $17.08 2023 Barostim Neo System
Altathera Pharmaceuticals LLC $15.87 2023 Sotalol Hydrochloride

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher R Ellis

$527,201.58

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $79K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/68747/christopher-r-ellis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.